Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

221: An Interview With Dutch Neurologist Ewout Groen of SMA Europe

 April 20, 2026

Rare Disease Audio

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Dutch neurologist Ewout Groen, PhD, a member of the Scientific Advisory Board of SMA Europe.

OtherRare DiseaseRead full story

Post navigation

AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle →
← FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com